Article
Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies.
Journal of visualized experiments : JoVE - 22 May 2020
Petriello Annalise, Becerra Jacob A, Lay Jason, Husaini Reem, Windler Sarah L, Duramad Omar, Liu Scot D
Abstract excerpt
One mechanism of action for clinical efficacy by therapeutic antibodies is the promotion of immune-related functions, such as cytokine secretion and cytotoxicity, driven by FcγRIIIa (CD16) expressed on natural killer (NK) cells. These observations have led to research focusing on methods to increase Fc receptor-mediated events, which include removal of a fucose moiety found on the Fc portion of the antibody....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
